tert-Butyl4-acetylbenzylcarbamate

Catalog No.: 
ACTIZY534
CAS No.: 
79533-04-3
Molecular Formula: 
C14H19NO3
Molecular Weight: 
249.31
tert-Butyl4-acetylbenzylcarbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$83.00In stockIn stock
1g95%$166.00In stockIn stock
5g95%$716.00In stockInquiry
25g95%$2749.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl4-acetylbenzylcarbamate
IUPAC Nametert-butyl (4-acetylbenzyl)carbamate
Molecular FormulaC14H19NO3
Molecular Weight249.31
SMILESO=C(OC(C)(C)C)NCC1=CC=C(C(C)=O)C=C1
InChI KeySNKHKDIMKZEHIA-UHFFFAOYSA-N
Synonymtert-Butyl (4-acetylphenyl)(methyl)carbamate;N-Boc-4-Acetylbenzylamine;TERT-BUTYL 4-ACETYLBENZYLCARBAMATE;Carbamic acid, N-[(4-acetylphenyl)methyl]-, 1,1-dimethylethyl ester
CAS No.79533-04-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACTIZY534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLOWJ015 route compound structure diagram
    ACLOWJ01542116-44-9In Stock
  4. Then
  5. ACTIZY534 route product structure diagram
    ACTIZY53479533-04-3In Stock
Inquiry

2. ACTIZY534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWHT590 route compound structure diagram
    ACYWHT59066522-66-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTIZY534 route product structure diagram
    ACTIZY53479533-04-3In Stock
Inquiry

3. ACTIZY534 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTIZY534 route product structure diagram
    ACTIZY53479533-04-3In Stock
Inquiry

Comments (0)